Boston Herald Opinion "Tom Mathers: CMS decision puts future disease cures in crosshairs"

From Boston Herald: My small biopharma company is developing a drug to treat a rare, fatal and presently incurable disease that afflicts one in 70,000 children.

We are working around-the-clock to test our medicine and get it approved by the Food and Drug Administration. But our job just got much harder because of an unprecedented action by another government agency — the Centers for Medicare and Medicaid Services. Read the full article here